After gene rearrangement, immunoglobulin (Ig) variable genes are diversified by somatic hypermutation (SHM), whereas the effector function of the constant domain is modified by class switch recombination (CSR). These processes depend on activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme expressed in B cells from secondary lymphoid organs on CD40 ligand (CD40L) stimulation. 1 Given that the absence of AID expression in one form of the hyper-IgM syndrome in humans 2 and in AID-targeted mice abolishes CSR and SHM, this protein is thought to play a major role in both processes. 3 Fifty percent of patients with chronic lymphocytic leukemia (CLL) display mutated V H genes. 4 The mutational profile of immunoglobulin genes represents an important prognostic factor 5,6 because patients expressing unmutated V H genes exhibit poor prognoses. In addition, previous reports 7-9 have demonstrated that CSR frequently occurs in CLL and predominates in unmutated B-cell CLLs (B-CLLs).
Introduction
After gene rearrangement, immunoglobulin (Ig) variable genes are diversified by somatic hypermutation (SHM), whereas the effector function of the constant domain is modified by class switch recombination (CSR). These processes depend on activation-induced cytidine deaminase (AID), a putative RNA-editing enzyme expressed in B cells from secondary lymphoid organs on CD40 ligand (CD40L) stimulation. 1 Given that the absence of AID expression in one form of the hyper-IgM syndrome in humans 2 and in AID-targeted mice abolishes CSR and SHM, this protein is thought to play a major role in both processes. 3 Fifty percent of patients with chronic lymphocytic leukemia (CLL) display mutated V H genes. 4 The mutational profile of immunoglobulin genes represents an important prognostic factor 5,6 because patients expressing unmutated V H genes exhibit poor prognoses. In addition, previous reports [7] [8] [9] have demonstrated that CSR frequently occurs in CLL and predominates in unmutated B-cell CLLs (B-CLLs).
In this work, we have examined the expression of AID transcripts, SHM, and CSR in 65 patients with CLL expressing either unmutated (33 of 65) or mutated (32 of 65) V H genes. Our results show that patients with unmutated B-CLL can constitutively express AID transcripts. This fact is associated with the presence of mutations in the preswitch DNA region and with an active CSR, but it is not related to the SHM process. Additionally, in patients with mutated CLL without constitutive AID expression, AID induction on stimulation results in preswitch mutations and the CSR process.
Study design Healthy and CLL samples
Blood was collected from 4 healthy controls and 65 typical CLL patients from Hôtel-Dieu, Pitié-Salpêtrière, and Pasteur hospitals (Paris, France), Sao Paulo and Servidor Publico Estadual hospitals (Sao Paulo, Brazil), and Hospital Maciel (Montevideo, Uruguay). B cells were purified through negative depletion by using RosetteSep antibody cocktail (StemCell Technologies, Vancouver, BC, Canada) and were stimulated in vitro for 5 days with 1 g/mL recombinant soluble CD40L (Immunex, Seattle, WA) and 1000 U/mL interleukin (IL)-4 (PharMingen, San Diego, CA).
Analysis of AID transcripts
Polymerase chain reaction (PCR) amplification of CLL cDNA was carried out as described previously, 2 and a semiquantitative protocol for AID expression was performed. Briefly, cDNA obtained from 5 ϫ 10 6 B cells was amplified by 20 cycles of PCR using AID 2 and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) 10 primers. The fragments obtained were transferred and hybridized with specific AID and GAPDH ␣-[ 32 P] dCTP (deoxycytidine-5Ј-triphosphate)-labeled probes.
Analysis of CSR process
PCR amplification of different isotype transcripts was performed as described by Oppezzo et al. 9 Circle isotype-specific (I-C) transcripts, termed circle transcripts (CTs), were analyzed by PCR with primers I-␥ (forward) and C-(reverse), as described by Kinoshita et al. 11 Mutation analysis of V H and preswitch regions Sequences of V H genes were determined as previously described. 12 Mutations in the I/S region were studied by PCR using Taq High Fidelity polymerase (Roche Diagnostics, Mannheim, Germany) with the following primers: (A) 5Ј-GGC TGA CCG AAA CTG AAA AGG C-3Ј; and (D) 5Ј-GAA AGC TGG ATG AGT GTC ATG GCC-3Ј.
Results and discussion
CLL B cells can constitutively express AID transcripts, which predominate among unmutated cases and are associated with the expression of additional clonally related transcripts Unmutated cases predominated among aggressive forms of CLL (25 of 34, stages B and C) whereas mutated cases predominated in stage A (23 of 31). By using a stringent semiquantitative reverse transcription (RT)-PCR, we could substantiate constitutive AID expression in 10 of 65 patients, which might have accounted for a lower incidence when compared with another series 13 ( Figure 1A ). Interestingly, all these patients expressed unmutated rearranged V H genes and displayed either advanced disease (stage B in 4) or progressive disease (stage A in 6). As shown in Figure 1B , different AID transcripts were amplified by RT-PCR, corresponding, respectively, to the complete sequence of AID transcript previously reported by Revy et al, 2 a fragment displaying a 10-amino acid deletion in the initial portion of exon 4, and a fragment with a 51-amino acid deletion including exons 4 and 5. Different AIDsplicing variants have also been reported by Noguchi et al. 14 The expression of constitutive AID transcripts in 10 unmutated patients led us to examine the CSR process by analysis of clonal isotype switch transcripts and the presence of ␥-CTs as recently reported in CLL by Cerutti et al. 15 Seven of these 10 CLLs expressed , ␦, ␥, and ␣ transcripts ( Figure 1C ), which were substantiated to display V H sequences identical to those expressed by the tumoral clone (data not shown). In addition, ␥-CTs were observed in all these unmutated patients, indicating that the initiation of a CSR process 11 is accounted for in these B-CLLs (data not shown).
AID expression enables CLL-B cells to carry out CSR somatic-like mutations but not SHM
To further investigate the dissociation between SHM and CSR in B-CLLs cells, taking into account that upon stimulation in the conditions that induce CSR, AID induction is associated with hypermutation in the S region under the conditions that induce CSR. 16 We have studied B cells from 4 healthy donors and 7 patients with CLL (4 unmutated and 3 mutated) before and after (Table 1) . Closed and open arrows indicate point mutations (30 in the 3Ј subregion, 9 in the 5Ј subregion). In addition, 4 deletions in the 3Ј subregion, depicted as rectangles, were observed. Open arrows illustrate where repeated mutations took place. Primers B (5Ј-TGC CTG TCT CTT ACC ATG TCG GG-3Ј) and C (5Ј-GAC ATG GTA AGA GAC AGG CAG CCG-3Ј) were used as internal primers for sequencing reaction. Given that in all cases 3 independent sequences obtained from different PCRs with a high-fidelity Taq DNA polymerase (10 Ϫ6 expected rate mutation) were carried out, Taq infidelity should play a minor, if any, role in the appearance of mutations.
stimulation with CD40L ϩ IL-4 and have considered AID expression by semiquantitative RT-PCR and CSR by searching of clonally related isotype variants, CTs, and somatic-like mutations in the preswitch DNA region. Figure 1D depicts the schematic amplified sequence of the preswitch region. Consistent with previous findings, 2 CD40L ϩ IL-4 stimulation induced the expression of AID transcripts ( Figure 1A) . After the exclusion of well-known polymorphisms, comparison of the sequences before and after stimulation demonstrated that AID induction was associated with a significant mutation rate (3 ϫ 10 Ϫ3 ) in the preswitch region. In agreement with previous reports, 16 a high number of these mutations were accumulated mainly in the 3Ј region of the amplified fragment ( Figure 1D ), indicating that a hypermutation process took place in the human Ig preswitch region and that this process was AID dependent. CLL patients 1, 2, 3, and 4 without SHM in V H genes were found to constitutively express AID, clonally related isotype variants, and a high rate of mutations in the preswitch region (Table 1 ). In addition, neither AID transcripts nor additional tumorally related transcripts were observed in CLL patients 5, 6, and 7 with V H mutations (Table 1 ) before CD40L ϩ IL-4 stimulation. However, AID transcripts and clonally related isotype variants were found for patients 5 and 7 on stimulation ( Figure 1C ).
AID may act as an RNA-editing enzyme involved in the edition of endonucleases responsible for CSR and SHM, 3, 17 either by editing a single substrate or separate pre-mRNAs for CSR and SHM. 18 On the other hand, recent evidence suggests that AID triggers antibody diversification by the deamination of nucleotides within the immunoglobulin locus itself. 19, 20 Different results suggest that AID is sufficient to activate the SHM and CSR processes and that its activity does not depend on other centroblast-specific factors. 19, 21, 22 Our results show, however, that AID expression is associated with CSR but not with SHM. This dissociation observed in CLL, combined with previous work in a mouse model 16 and in the BL2 Burkitt cell line, 23 favors the view that AID may act differentially on CSR and SHM. In agreement with recent work 24 demonstrating that with strong stimulation through the B-cell receptor (BCR), patients with CLL are able to acquire somatic mutations, our results suggest that AID is necessary but not sufficient for the SHM process, and that additional levels of regulation could be required for the efficient function of this protein. 
